These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31915289)

  • 1. The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes.
    Weinstein MP; Lewis JS
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31915289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Changes to the Clinical and Laboratory Standards Institute
    Humphries R; Bobenchik AM; Hindler JA; Schuetz AN
    J Clin Microbiol; 2021 Nov; 59(12):e0021321. PubMed ID: 34550809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach.
    Pierce VM; Mathers AJ
    J Pediatric Infect Dis Soc; 2022 Feb; 11(2):73-80. PubMed ID: 34888640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.
    Ellington MJ; Ekelund O; Aarestrup FM; Canton R; Doumith M; Giske C; Grundman H; Hasman H; Holden MTG; Hopkins KL; Iredell J; Kahlmeter G; Köser CU; MacGowan A; Mevius D; Mulvey M; Naas T; Peto T; Rolain JM; Samuelsen Ø; Woodford N
    Clin Microbiol Infect; 2017 Jan; 23(1):2-22. PubMed ID: 27890457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists.
    Wenzler E; Maximos M; Asempa TE; Biehle L; Schuetz AN; Hirsch EB
    Pharmacotherapy; 2023 Apr; 43(4):264-278. PubMed ID: 36825480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.
    Humphries RM; Abbott AN; Hindler JA
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30971460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM; Astles JR; Tenover FC; Hindler J
    J Clin Microbiol; 2007 Jul; 45(7):2230-4. PubMed ID: 17522281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revision of fluoroquinolone breakpoints used for interpretation of antimicrobial susceptibility testing of canine bacterial isolates.
    Papich MG; Gunnett LA; Lubbers BV
    Am J Vet Res; 2023 Nov; 84(11):. PubMed ID: 37673214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023.
    Pierce VM; Bhowmick T; Simner PJ
    J Clin Microbiol; 2023 Nov; 61(11):e0007422. PubMed ID: 37768094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of methods used for antimicrobial susceptibility testing in veterinary diagnostic laboratories in the United States.
    Dargatz DA; Erdman MM; Harris B
    J Vet Diagn Invest; 2017 Sep; 29(5):669-675. PubMed ID: 28599616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute.
    Satlin MJ; Nicolau DP; Humphries RM; Kuti JL; Campeau SA; Lewis Ii JS; Weinstein MP; Jorgensen JH
    Clin Infect Dis; 2020 Mar; 70(6):1240-1246. PubMed ID: 31504338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How New Regulation of Laboratory-Developed Antimicrobial Susceptibility Tests Will Affect Infectious Diseases Clinical Practice.
    Wolfe KH; Pierce VM; Humphries RM
    Clin Infect Dis; 2024 May; 78(5):1140-1147. PubMed ID: 38573057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee Advisory.
    Simner PJ; Palavecino EL; Satlin MJ; Mathers AJ; Weinstein MP; Lewis JS; Humphries R
    J Clin Microbiol; 2023 Apr; 61(4):e0160022. PubMed ID: 36946754
    [No Abstract]   [Full Text] [Related]  

  • 15. Driving Laboratory Standardization of Bacterial Culture and Antimicrobial Susceptibility Testing in Veterinary Clinical Microbiology in Europe and Beyond.
    Timofte D; Broens EM; Guardabassi L; Pomba C; Allerton F; Ikonomopoulos J; Overesch G; Damborg P;
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33361339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
    Süzük S; Kaşkatepe B; Avcıküçük H; Aksaray S; Başustaoğlu A
    Mikrobiyol Bul; 2015 Oct; 49(4):494-501. PubMed ID: 26649407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute.
    Humphries RM; Green DA; Schuetz AN; Bergman Y; Lewis S; Yee R; Stump S; Lopez M; Macesic N; Uhlemann AC; Kohner P; Cole N; Simner PJ
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan.
    Hsueh PR; Ko WC; Wu JJ; Lu JJ; Wang FD; Wu HY; Wu TL; Teng LJ
    J Microbiol Immunol Infect; 2010 Oct; 43(5):452-5. PubMed ID: 21075714
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.
    Humphries RM; Hindler JA
    Clin Infect Dis; 2016 Jul; 63(1):83-8. PubMed ID: 27025822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022.
    Patel JB; Alby K; Humphries R; Weinstein M; Lutgring JD; Naccache SN; Simner PJ
    J Clin Microbiol; 2023 Oct; 61(10):e0115422. PubMed ID: 37791777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.